GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 348 filers reported holding GLOBUS MED INC in Q4 2020. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $148,247,822 | +24.7% | 1,996,066 | 0.0% | 0.04% | +15.4% |
| Q3 2022 | $118,906,000 | +19.6% | 1,996,066 | +12.8% | 0.04% | +25.8% |
| Q2 2022 | $99,385,000 | -29.1% | 1,770,315 | -6.9% | 0.03% | -11.4% |
| Q1 2022 | $140,264,000 | +2.2% | 1,901,114 | 0.0% | 0.04% | +16.7% |
| Q4 2021 | $137,260,000 | -8.5% | 1,901,114 | -2.9% | 0.03% | -14.3% |
| Q3 2021 | $150,084,000 | -5.7% | 1,958,807 | -4.6% | 0.04% | -5.4% |
| Q2 2021 | $159,187,000 | +25.7% | 2,053,234 | 0.0% | 0.04% | +19.4% |
| Q1 2021 | $126,623,000 | +1.3% | 2,053,234 | +7.1% | 0.03% | -3.1% |
| Q4 2020 | $125,001,000 | +108.1% | 1,916,600 | +58.0% | 0.03% | +77.8% |
| Q3 2020 | $60,078,000 | -12.7% | 1,213,200 | -15.9% | 0.02% | -18.2% |
| Q2 2020 | $68,822,000 | +57.8% | 1,442,500 | +40.7% | 0.02% | +29.4% |
| Q1 2020 | $43,604,000 | – | 1,025,250 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 908,953 | $59,282,000 | 5.54% |
| Sterling Investment Advisors, Ltd. | 234,623 | $15,302,000 | 5.20% |
| Next Capital Management LLC | 111,098 | $7,246,000 | 5.10% |
| Godshalk Welsh Capital Management, Inc. | 77,085 | $5,027,000 | 3.71% |
| Pembroke Management, LTD | 613,931 | $40,041,000 | 3.36% |
| XXEC, Inc. | 52,800 | $3,444,000 | 2.71% |
| Global Alpha Capital Management Ltd. | 302,377 | $19,721,000 | 2.42% |
| Van Berkom & Associates Inc. | 1,572,303 | $102,546,000 | 2.35% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 581,700 | $37,939,000 | 2.27% |
| RTW INVESTMENTS, LP | 1,640,859 | $107,017,000 | 1.80% |